9 reports

However, strong pipeline and increased outsourcing of drug development will offset this negative impact.

  • Lymphoma
  • Hoffmann-La Roche Inc.
  • ImmunoGen, Inc.
  • Seattle Genetics, Inc.
  • Takeda Pharmaceutical Company Limited

THE IMMUNOTHERAPEUTIC DRUG MANUFACTURERS FROM NORTH AMERICA ARE SUPPOSED TO INCREASE THE OUTSOURCING ACTIVITIES.

  • Lymphoma
  • AbbVie Inc.
  • Amgen Inc.
  • Biogen Idec Inc.
  • Bristol-Myers Squibb Company

THIS HAS TO BE DONE BY FULL PARTNERSHIP OR FULL OUTSOURCING AND WE SEE MORE AND MORE OF OUTSOURCING TO GET ACCESS TO SPECIFIC TECHNOLOGY.

  • Lymphoma
  • Demand
  • Market Size
  • AbbVie Inc.
  • Seattle Genetics, Inc.

Business Developments Acquisitions & Outsourcing Cash Flow and Financing Total acquisition spend in 2015 was ca.

  • Lymphoma
  • Pharmaceutical
  • United States
  • M&A
  • Kite Pharma, Inc.

outsourcing and manufacturing of clinical trial material.

  • Dermatological Condition
  • Lymphoma
  • Therapy
  • United States
  • Product Initiative
  • Cancer
  • Lymphoma
  • United States
  • Company
  • Product Initiative

outsourcing services in the Americas, Europe, Asia Pacific and Africa.

  • Healthcare
  • Lymphoma
  • Pharmaceutical
  • Therapy
  • Eisai Co., Ltd.

outsourcing services in the Americas, Europe, Asia Pacific and Africa.

  • Healthcare
  • Lymphoma
  • Pharmaceutical
  • Therapy
  • Eisai Co., Ltd.

Istesso offers its project development services through outsourcing the early development work to contract research organizations and research institutions.

  • Cancer
  • Lymphoma
  • Monoclonal Antibody
  • Pathology
  • Bristol-Myers Squibb Company